Fredrik Frejd
CSO Affibody AB
Seminars
Tuesday 11th November 2025
HER2 Targeted Affibody Radioligand Therapy: Rationale & First in Human Design
1:30 pm
- Translating mouse data to clinical doses
- Considering novel imaging diagnostic versus histochemistry gold standard
- Developing riskadjusted stepwise clinical development path
